Research / VRSN / Fundamental state Inspectable configuration
State dimensions Filing 0001014473-26-000028 General Corporate
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.33% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
53.29% · OPTIONAL · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
6.03% · CORE · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
88.50% · CORE · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
68.18% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.33% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.46% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 5/5 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 6/6 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.68%
Current 4.33%
Delta 2.65% Cash Generation Decreased
Previous 63.51%
Current 53.29%
Delta -10.22% Growth Decreased
Previous 6.61%
Current 6.03%
Delta -0.59% Margin Decreased
Previous 88.53%
Current 88.50%
Delta -0.03% Profitability Decreased
Previous 68.45%
Current 68.18%
Delta -0.28% R And D Intensity Decreased
Previous 6.41%
Current 6.33%
Delta -0.08% Sbc Intensity Increased
Previous 4.45%
Current 4.46%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Sep 30, 2022
Similarity 91%
Compared 5 dimensions
Coverage 71% Margin 0.0 · Profitability 10.0 · Sbc Intensity 5.0 · Capex Intensity 15.0 · R And D Intensity 5.0 Mar 31, 2026
Similarity 75%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Margin 5.0 · Profitability 5.0 · Sbc Intensity 0.0 · Capex Intensity 55.0 · Cash Generation 35.0 · R And D Intensity 5.0 Jun 30, 2021
Similarity 73%
Compared 7 dimensions
Coverage 100% Growth 22.3 · Margin 24.4 · Profitability 32.9 · Sbc Intensity 47.9 · Capex Intensity 9.1 · Cash Generation 19.1 · R And D Intensity 13.2 Dec 31, 2023
Similarity 70%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Margin 0.0 · Profitability 10.0 · Sbc Intensity 65.0 · Capex Intensity 45.0 · Cash Generation 0.0 · R And D Intensity 5.0 Dec 31, 2021
Similarity 68%
Compared 7 dimensions
Coverage 100% Growth 23.3 · Margin 26.6 · Profitability 16.8 · Sbc Intensity 68.7 · Capex Intensity 11.3 · Cash Generation 27.6 · R And D Intensity 14.5 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.